GlassScriptPhysician profile
Raymond C Perkins
NPI 1548268501
$99,347.51
in general payments reported to CMS, 2019-2025
25 companies · $1,346 in 2025
The $1,346 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $13K · 2021: $18K · 2022: $20K · 2023: $14K · 2024: $17K · 2025: $1,346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Food and Beverage: $4,663 · Education: $57.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,625.00 |
| Food and Beverage | $4,662.53 |
| Education | $57.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $69,368.41 | 2020-2025 | Arexvy, Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23,023.29 | 2019-2025 | Ofev |
| Astrazeneca Pharmaceuticals LP | $4,778.13 | 2020-2025 | Fasenra, Airsupra, Tezspire |
| United Therapeutics Corporation | $424.70 | 2023-2025 | Tyvaso, Tyvaso |
| Electromed, INC. | $291.39 | 2024-2025 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $193.97 | 2024-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $180.91 | 2023-2025 | |
| Harmony Biosciences LLC | $141.94 | 2022-2024 | Wakix |
| Genzyme Corporation | $134.54 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $133.98 | 2024-2025 | Purified Cortrophin Gel |
| Mylan Specialty L.P. | $97.68 | 2024 | Yupelri |
| Inspire Medical Systems, INC. | $83.53 | 2023-2024 | Inspire |
| Viatris Specialty LLC | $80.35 | 2025 | Yupelri |
| Amgen INC. | $79.95 | 2024-2025 | Tezspire |
| Takeda Pharmaceuticals U.S.A., INC. | $71.82 | 2024-2025 | Glassia |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $47.36 | 2024-2025 | Zerbaxa, Winrevair |
| Tactile Systems Technology INC | $37.17 | 2025 | Flexitouch Plus, Nimbl |
| Grifols USA, LLC | $33.64 | 2025 | Prolastin-C Liquid |
| Verona Pharma, INC. | $28.07 | 2025 | Ohtuvayre |
| Philips North America LLC | $25.67 | 2019-2023 | |
| Theratechnologies INC. | $23.85 | 2025 | Egrifta, Trogarzo |
| Paratek Pharmaceuticals, INC. | $22.30 | 2025 | Nuzyra |
| Avadel Cns Pharmaceuticals, LLC | $15.53 | 2025 | Lumryz |
| Baxter Healthcare | $15.31 | 2023 | Hillrom - Life 2000 Ventilation System |
| Becton, Dickinson and Company | $14.02 | 2025 | Hemosphere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Perkins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.